Letter: Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland Cryoablation: A Prospective Cohort Study of Men With Intermediate-Risk Prostate Cancer

No AccessJournal of UrologyLetters to the Editor14 Nov 2023Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland Cryoablation: A Prospective Cohort Study of Men With Intermediate-Risk Prostate Cancer. Letter. Yuliang Chen, Zhen Liang, and Weigang Yan Yuliang ChenYuliang Chen Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China More articles by this author , Zhen LiangZhen Liang Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China More articles by this author , and Weigang YanWeigang Yan *Corresponding Author: Weigang Yan, Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 1 Wangfujing Shuaifuyuan, Beijing100730, China E-mail Address: [email protected] Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003781AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland Cryoablation: A Prospective Cohort Study of Men With Intermediate-Risk Prostate Cancer. Letter.." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. . Biopsy assessment of oncologic control 3 years following primary partial gland cryoablation: a prospective cohort study of men with intermediate-risk prostate cancer. J Urol.2023; 210(3):454-464. Link, Google Scholar 2. . Real-time US versus CT determination of pubic arch interference for brachytherapy. Radiology. 2001; 219(2):387-393. Crossref, Medline, Google Scholar 3. . Role of hydrogel spacer to protect the rectum from thermal injury in focal therapy of prostate cancer: preclinical study in cadaver model. Int J Urol. 2023; 30(1):116-118. Crossref, Medline, Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.Metrics Author Information Yuliang Chen Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China More articles by this author Zhen Liang Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China More articles by this author Weigang Yan Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China *Corresponding Author: Weigang Yan, Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 1 Wangfujing Shuaifuyuan, Beijing100730, China E-mail Address: [email protected] More articles by this author Expand All Advertisement PDF downloadLoading ...